Bayban’s HealthEquity HQY Stock Holding History

Bayban’s Portfolio HQY Stock Details HQY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.62K	Hold	29	–	–	﹤0.01%	521
2026 Q1	$2.42K	Hold	29	–	–	﹤0.01%	547
2025 Q4	$2.66K	Buy	+29	New	+$2.78K	﹤0.01%	526

Other funds holding HQY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Bayban's HQY Position: Q2 2026 in Review

Bayban held its HealthEquity (HQY) position steady in Q2 2026 at 29 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #521.

Bayban first reported a position in HQY in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.66K in Q4 2025. 468 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

Bayban held 29 shares of HealthEquity worth $2.62K as of Q2 2026.
Bayban left its HealthEquity share count unchanged in Q2 2026.
HealthEquity made up ﹤0.01% of Bayban's portfolio in Q2 2026, its #521 holding.
Bayban first reported a position in HealthEquity in Q4 2025 and has held it in 3 quarters since.
Bayban's HealthEquity position peaked at $2.66K in Q4 2025.
468 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.